Difference between revisions of "Team:Pasteur Paris/Protocol"

Line 231: Line 231:
 
     <tr>
 
     <tr>
 
       <td><strong><p>Antibody-binding Protocol</p></strong></td>
 
       <td><strong><p>Antibody-binding Protocol</p></strong></td>
       <td> </td>
+
       <td> The goal is to determine whether our immunoassay is effective. We want to ensure that our antibodies are well able to detect the presence or absence of viral proteins from Chikungunya and Yellow Fever viruses.
       <td> <center><a href=""><img src="https://static.igem.org/mediawiki/2016/5/53/Antibody_Pasteur_PARIS_2016.png" width="40%" alt=""></a></center></td>
+
</td>
 +
       <td> <center><a href="https://static.igem.org/mediawiki/2016/2/21/T--Pasteur_Paris--Immunoassay_Protocol.pdf"><img src="https://static.igem.org/mediawiki/2016/5/53/Antibody_Pasteur_PARIS_2016.png" width="40%" alt=""></a></center></td>
 
     </tr>
 
     </tr>
  

Revision as of 19:57, 18 October 2016